Invested in Trailhead Biosystems, a Cleveland Clinic spinout using data-driven discovery to mass-produce differentiated human cell lines for drug discovery.
Trailhead Biosystems is pioneering the informatics-based approach in regenerative medicine and drug discovery, specializing in the precise differentiation of induced pluripotent stem cells (iPSCs) into functional human cell types using their proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform
Trailhead Biosystems is pioneering the informatics-based approach in regenerative medicine and drug discovery, specializing in the precise differentiation of induced pluripotent stem cells (iPSCs) into functional human cell types using their proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform.